SOMAXON PHARMACEUTICALS, INC. Research and Development Expense
SOMAXON PHARMACEUTICALS, INC. reported Research and Development Expense of $1.30 million for the 12-month period ending 2011-12-31, per its 10-K filed 2012-03-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2012-11-01
- SOMAXON PHARMACEUTICALS, INC. research and development expense for the quarter ending 2011-12-31 was $178.00K, a 71.52% decline year-over-year.
- SOMAXON PHARMACEUTICALS, INC. research and development expense for the quarter ending 2011-09-30 was $242.00K, a 76.13% decline year-over-year.
- SOMAXON PHARMACEUTICALS, INC. research and development expense for the quarter ending 2011-06-30 was $457.00K, a 43.86% decline year-over-year.
- SOMAXON PHARMACEUTICALS, INC. research and development expense for the quarter ending 2011-03-31 was $419.00K.
- SOMAXON PHARMACEUTICALS, INC. research and development expense for fiscal 2011 was $1.30M, a 63.66% decline from fiscal 2010.
- SOMAXON PHARMACEUTICALS, INC. research and development expense for fiscal 2010 was $3.57M, a 17.78% decline from fiscal 2009.
- SOMAXON PHARMACEUTICALS, INC. research and development expense for fiscal 2009 was $4.34M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2011-12-31 | $178.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-09 | $420.00K derived: sum of 2 quarters · filed 2012-11-01 | $877.00K derived: sum of 3 quarters · filed 2012-11-01 | $1.30M 10-K · filed 2012-03-09 |
| 2011-09-30 | $242.00K 10-Q · filed 2012-11-01 | $699.00K derived: sum of 2 quarters · filed 2012-11-01 | $1.12M 10-Q · filed 2012-11-01 | $1.74M derived: sum of 4 quarters · filed 2012-11-01 |
| 2011-06-30 | $457.00K 10-Q · filed 2012-08-08 | $876.00K 10-Q · filed 2012-08-08 | $1.50M derived: sum of 3 quarters · filed 2012-08-08 | $2.52M derived: sum of 4 quarters · filed 2012-08-08 |
| 2011-03-31 | $419.00K 10-Q · filed 2012-05-10 | $1.04M derived: sum of 2 quarters · filed 2012-05-10 | $2.06M derived: sum of 3 quarters · filed 2012-05-10 | $2.87M derived: sum of 4 quarters · filed 2012-05-10 |
| 2010-12-31 | $625.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-09 | $1.64M derived: sum of 2 quarters · filed 2012-03-09 | $2.45M derived: sum of 3 quarters · filed 2012-03-09 | $3.57M 10-K · filed 2012-03-09 |
| 2010-09-30 | $1.01M 10-Q · filed 2011-11-04 | $1.83M derived: sum of 2 quarters · filed 2011-11-04 | $2.94M 10-Q · filed 2011-11-04 | |
| 2010-06-30 | $814.00K 10-Q · filed 2011-08-03 | $1.93M 10-Q · filed 2011-08-03 | ||
| 2009-12-31 | $4.34M 10-K · filed 2012-03-09 |